Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06392269 · ClinicalTrials.gov registry record
A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing
A clinical trial, sponsored by Tasso.
- Completed
- Registry status
- 443
- Enrollment target
NCT06392269 is a clinical trial that has completed, run by Tasso. The registered enrollment target is 443 participants.
The verdict
NCT06392269 has completed, sponsored by Tasso.
- COMPLETED
- Registry status
- 443 participants
- Enrollment target
Study Summary
This is a prospective, multi-center study within the U.S. Study participants will take part in two study visits a minimum of 14 days apart. During each visit, participants will self-collect capillary blood samples. Additionally, a healthcare provide will obtain capillary and venous serum samples. All capillary samples will be collected from the upper arm using the Tasso+ device paired with a commercially-available serum separator gel microtainer. The samples will be shipped to a clinical laboratory and tested for various analytes. Expected analyte values for each participant will be based on their venous sample results which will be compared to Tasso sample results
Interventions
- DIAGNOSTIC_TEST Tasso+SST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 443 participants |
| Start Date | 2024-03-18 |
| Est. Completion | 2025-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06392269
The ClinicalTrials.gov registry entry for NCT06392269 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 443 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tasso, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tasso+SST is the first listed.
NCT06392269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06392269 about?
NCT06392269 is a clinical study titled "A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing". This is a prospective, multi-center study within the U.S. Study participants will take part in two study visits a minimum of 14 days apart. During each visit, participants will self-collect capillary blood samples. Additionally, a healthcare provide will obtain capillary and venous serum samples. Al...
What is the current status of trial NCT06392269?
This trial is currently completed. The enrollment target is 443 participants. The study started on 2024-03-18. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT06392269?
The interventions under investigation include: Tasso+SST (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06392269?
This trial is sponsored by Tasso, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.